{"id":350398,"date":"2026-11-17T14:45:53","date_gmt":"2026-11-17T09:15:53","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=350398"},"modified":"2026-11-17T14:45:53","modified_gmt":"2026-11-17T09:15:53","slug":"home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list\/","title":{"rendered":"3 Home Care and Textile Chemicals Maker, Multi Speciality Hospitals Group and Data Analytics Company Stocks With a Strong Future Roadmap: Rossari Biotech, Narayana Hrudayalaya and Latent View Analytics"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Rossari Biotech, Narayana Hrudayalaya and Latent View Analytics: ROE of 10.8% to 17.8% and FY22 to FY26 revenue CAGR of 12.8% to 27.6%. Prices as of 16 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three <strong>biotech chemical, heart care and data stocks<\/strong> to watch are <strong>Rossari Biotech<\/strong>, <strong>Narayana Hrudayalaya<\/strong> and <strong>Latent View Analytics<\/strong>. Their <strong>return on equity<\/strong> ranges from <strong>10.8% to 17.8%<\/strong>, and their <strong>revenue compound annual growth<\/strong> from FY22 to FY26 ranges from 12.8% to 27.6%. Narayana Hrudayalaya has the highest return on equity at 17.8%, while Latent View Analytics has the fastest revenue growth at 27.6% a year. Prices are based on the 16 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Biotech chemical, heart care and data stocks give investors a way to track businesses that sit close to everyday demand in India. Rossari Biotech, Narayana Hrudayalaya and Latent View Analytics cover a home care and textile chemicals maker, a multi speciality hospitals group and a data analytics company.<\/p>\n<p>This list covers three biotech chemical, heart care and data stocks with complete current figures: Rossari Biotech, Narayana Hrudayalaya and Latent View Analytics. Every figure comes from the latest reported financials and the 16 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list\/#What_Are_Biotech_Chemical_Heart_Care_and_Data_Stocks\" title=\"What Are Biotech Chemical, Heart Care and Data Stocks?\">What Are Biotech Chemical, Heart Care and Data Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list\/#Biotech_Chemical_Heart_Care_and_Data_Stocks_at_a_Glance\" title=\"Biotech Chemical, Heart Care and Data Stocks at a Glance\">Biotech Chemical, Heart Care and Data Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list\/#Why_Do_Biotech_Chemical_Heart_Care_and_Data_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Biotech Chemical, Heart Care and Data Stocks Have a Strong Roadmap in India?\">Why Do Biotech Chemical, Heart Care and Data Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list\/#Why_Rossari_Biotech_Features_Among_These_Biotech_Chemical_Heart_Care_and_Data_Stocks\" title=\"Why Rossari Biotech Features Among These Biotech Chemical, Heart Care and Data Stocks\">Why Rossari Biotech Features Among These Biotech Chemical, Heart Care and Data Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list\/#Why_Narayana_Hrudayalaya_Features_Among_These_Biotech_Chemical_Heart_Care_and_Data_Stocks\" title=\"Why Narayana Hrudayalaya Features Among These Biotech Chemical, Heart Care and Data Stocks\">Why Narayana Hrudayalaya Features Among These Biotech Chemical, Heart Care and Data Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list\/#Why_Latent_View_Analytics_Features_Among_These_Biotech_Chemical_Heart_Care_and_Data_Stocks\" title=\"Why Latent View Analytics Features Among These Biotech Chemical, Heart Care and Data Stocks\">Why Latent View Analytics Features Among These Biotech Chemical, Heart Care and Data Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list\/#Rossari_Biotech_vs_Narayana_Hrudayalaya_vs_Latent_View_Analytics_on_Key_Financials\" title=\"Rossari Biotech vs Narayana Hrudayalaya vs Latent View Analytics on Key Financials\">Rossari Biotech vs Narayana Hrudayalaya vs Latent View Analytics on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list\/#Key_Risks_to_Check_Before_Investing_in_Biotech_Chemical_Heart_Care_and_Data_Stocks\" title=\"Key Risks to Check Before Investing in Biotech Chemical, Heart Care and Data Stocks\">Key Risks to Check Before Investing in Biotech Chemical, Heart Care and Data Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list\/#Final_Thoughts_on_Biotech_Chemical_Heart_Care_and_Data_Stocks\" title=\"Final Thoughts on Biotech Chemical, Heart Care and Data Stocks\">Final Thoughts on Biotech Chemical, Heart Care and Data Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list\/#What_are_biotech_chemical_heart_care_and_data_stocks\" title=\"What are biotech chemical, heart care and data stocks?\">What are biotech chemical, heart care and data stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list\/#Which_biotech_chemical_heart_care_and_data_stocks_are_covered_in_this_list\" title=\"Which biotech chemical, heart care and data stocks are covered in this list?\">Which biotech chemical, heart care and data stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list\/#Why_do_biotech_chemical_heart_care_and_data_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do biotech chemical, heart care and data stocks have a strong future roadmap in India?\">Why do biotech chemical, heart care and data stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list\/#How_has_Rossari_Biotech_performed_financially\" title=\"How has Rossari Biotech performed financially?\">How has Rossari Biotech performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list\/#How_has_Narayana_Hrudayalaya_performed_financially\" title=\"How has Narayana Hrudayalaya performed financially?\">How has Narayana Hrudayalaya performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list\/#How_has_Latent_View_Analytics_performed_financially\" title=\"How has Latent View Analytics performed financially?\">How has Latent View Analytics performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list\/#What_risks_should_investors_check_before_buying_biotech_chemical_heart_care_and_data_stocks\" title=\"What risks should investors check before buying biotech chemical, heart care and data stocks?\">What risks should investors check before buying biotech chemical, heart care and data stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and-data-analytics-company-stocks-roadmap-downland-list\/#Is_this_list_of_biotech_chemical_heart_care_and_data_stocks_investment_advice\" title=\"Is this list of biotech chemical, heart care and data stocks investment advice?\">Is this list of biotech chemical, heart care and data stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Biotech_Chemical_Heart_Care_and_Data_Stocks\"><\/span><strong>What Are Biotech Chemical, Heart Care and Data Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Biotech chemical, heart care and data stocks<\/strong> are listed companies that make specialty chemicals for home care, textiles and animal care, run multi speciality hospitals with a focus on heart care, and provide data analytics services to global clients. Their earnings depend on chemical demand, patient volumes and client technology budgets.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Biotech_Chemical_Heart_Care_and_Data_Stocks_at_a_Glance\"><\/span><strong>Biotech Chemical, Heart Care and Data Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/rossari\/rossari-biotech-ltd-share-price-today\">Rossari Biotech<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">427.15<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,363<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">33.9<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.28<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/nh\/narayana-hrudayalaya-ltd-share-price-today\">Narayana Hrudayalaya<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,895.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">35,603<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">43.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">59.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1.29<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/latentview\/latent-view-analytics-ltd-share-price-today\">Latent View Analytics<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">201.51<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4,968<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">25.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.02<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, Rossari Biotech and Narayana Hrudayalaya trade at a <strong>P\/E<\/strong> below the industry P\/E, while Latent View Analytics trades above it, which reflects the growth the market already expects. Readers comparing biotech chemical, heart care and data stocks should look at <strong>return on equity<\/strong> and debt together, since a high return earned with low debt is easier to sustain.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Biotech_Chemical_Heart_Care_and_Data_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Biotech Chemical, Heart Care and Data Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Biotech chemical, heart care and data stocks have a strong roadmap in India because wider use of specialty chemicals, rising need for affordable specialist care and growing use of data in business decisions keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Specialty chemicals.<\/strong> Brands need niche formulation inputs.<\/li>\n<li><strong>Heart hospitals.<\/strong> Families seek affordable specialist care.<\/li>\n<li><strong>Data analytics.<\/strong> Firms use data to decide faster.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Rossari_Biotech_Features_Among_These_Biotech_Chemical_Heart_Care_and_Data_Stocks\"><\/span><strong>Why Rossari Biotech Features Among These Biotech Chemical, Heart Care and Data Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the <strong>biotech chemical, heart care and data stocks<\/strong> on this list, Rossari Biotech makes specialty chemicals for home, personal and performance applications, including textile chemicals, animal health and nutrition products and ingredients for fast-moving consumer goods.<\/p>\n<p>Revenue rose from Rs 1,495 crore in FY22 to Rs 2,419 crore in FY26, a compound annual growth rate of 12.8%. Net profit grew from Rs 97.7 crore in FY22 to Rs 149 crore in FY26, which works out to a compound annual growth rate of 11.2%.<\/p>\n<p>The company has a return on equity of 10.8%, a debt to equity ratio of 0.28 and a <strong>market capitalisation<\/strong> of Rs 2,363 crore. The stock trades at a <strong>P\/E<\/strong> of 15.5, below the industry P\/E of 33.9.<\/p>\n<p><strong>Roadmap:<\/strong> The company is broadening its range across home and personal care, animal nutrition and performance chemicals. Cross-selling to existing customers helps add volume.<\/p>\n<p><strong>What to watch:<\/strong> Track new product additions, customer wins and margin trends.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Narayana_Hrudayalaya_Features_Among_These_Biotech_Chemical_Heart_Care_and_Data_Stocks\"><\/span><strong>Why Narayana Hrudayalaya Features Among These Biotech Chemical, Heart Care and Data Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the home care ingredient, cardiac care and data science shares on this list, Narayana Hrudayalaya, widely known as Narayana Health, is a Bengaluru-based hospital group built around affordable cardiac care that now covers multiple specialities across India and also operates in the Cayman Islands.<\/p>\n<p>Revenue rose from Rs 3,736 crore in FY22 to Rs 7,996 crore in FY26, a compound annual growth rate of 21.0%. Net profit grew from Rs 342 crore in FY22 to Rs 810 crore in FY26, which works out to a compound annual growth rate of 24.1%.<\/p>\n<p>The company has a return on equity of 17.8%, a debt to equity ratio of 1.29 and a market capitalisation of Rs 35,603 crore. The stock trades at a P\/E of 43.6, below the industry P\/E of 59.6.<\/p>\n<p><strong>Roadmap:<\/strong> Growth is coming from bed additions across its hospital clusters, a rising share of higher-value specialities and an expanding insurance-led patient base. The group has a track record of running hospitals at high efficiency, which supports margins as scale builds.<\/p>\n<p><strong>What to watch:<\/strong> Keep an eye on occupancy in newly added beds and the payor mix between insurance and cash patients.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Latent_View_Analytics_Features_Among_These_Biotech_Chemical_Heart_Care_and_Data_Stocks\"><\/span><strong>Why Latent View Analytics Features Among These Biotech Chemical, Heart Care and Data Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Latent View Analytics, headquartered in Chennai, provides data analytics, engineering and artificial intelligence services to technology, consumer and financial clients worldwide.<\/p>\n<p>The company has a return on equity of 11.3%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 4,968 crore. The stock trades at a P\/E of 25.0, above the industry P\/E of 17.5.<\/p>\n<p>Revenue rose from Rs 429 crore in FY22 to Rs 1,136 crore in FY26, a compound annual growth rate of 27.6%. Net profit grew from Rs 130 crore in FY22 to Rs 202 crore in FY26, which works out to a compound annual growth rate of 11.8%. In the June 2026 quarter, revenue grew 18.8% year on year to Rs 308 crore.<\/p>\n<p><strong>Roadmap:<\/strong> Enterprises are investing in analytics and artificial intelligence, which feeds demand for data services. The company is widening its client list and scaling large accounts with a consulting and engineering model.<\/p>\n<p><strong>What to watch:<\/strong> Follow client additions and the growth of large accounts.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Rossari_Biotech_vs_Narayana_Hrudayalaya_vs_Latent_View_Analytics_on_Key_Financials\"><\/span><strong>Rossari Biotech vs Narayana Hrudayalaya vs Latent View Analytics on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three biotech chemical, heart care and data stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Rossari Biotech<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,495<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,419<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.8%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">149<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Narayana Hrudayalaya<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,736<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7,996<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.0%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">810<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Latent View Analytics<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">429<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,136<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">27.6%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">202<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.8%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Narayana Hrudayalaya posts the highest return on equity in this group at 17.8%. Narayana Hrudayalaya has the largest FY26 revenue at Rs 7,996 crore, and Latent View Analytics shows the fastest revenue growth with a 27.6% compound annual rate. A useful habit with biotech chemical, heart care and data stocks is to check each new quarterly result against the capacity plans the company described earlier.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Biotech_Chemical_Heart_Care_and_Data_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Biotech Chemical, Heart Care and Data Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these <strong>biotech chemical, heart care and data stocks<\/strong>, the main points are: Long-term home care ingredient, cardiac care and data science shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Raw material and energy costs.<\/strong> Input prices can move margins in chemicals.<\/li>\n<li><strong>Capacity ramp up.<\/strong> New hospitals take time to fill beds and reach full returns.<\/li>\n<li><strong>Currency moves.<\/strong> Export earnings move with the rupee.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter biotech chemical, heart care and data stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Biotech_Chemical_Heart_Care_and_Data_Stocks\"><\/span><strong>Final Thoughts on Biotech Chemical, Heart Care and Data Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Biotech chemical, heart care and data stocks work best when investors track growth, valuation and return on equity side by side. Rossari Biotech, Narayana Hrudayalaya and Latent View Analytics each have a clear plan to grow. Based on the 16 November 2026 close, Rossari Biotech trades at Rs 427.15, Narayana Hrudayalaya at Rs 1,895.3 and Latent View Analytics at Rs 201.51.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track biotech chemical, heart care and data stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_biotech_chemical_heart_care_and_data_stocks\"><\/span><strong>What are biotech chemical, heart care and data stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> <strong>Biotech chemical, heart care and data stocks<\/strong> are listed companies that make specialty chemicals for home care, textiles and animal care, run multi speciality hospitals with a focus on heart care, and provide data analytics services to global clients. Their earnings depend on chemical demand, patient volumes and client technology budgets. This list looks at three of them, Rossari Biotech, Narayana Hrudayalaya and Latent View Analytics, using reported FY22 to FY26 financials and the 16 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_biotech_chemical_heart_care_and_data_stocks_are_covered_in_this_list\"><\/span><strong>Which biotech chemical, heart care and data stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Rossari Biotech, Narayana Hrudayalaya and Latent View Analytics. Based on the 16 November 2026 close, Rossari Biotech traded at Rs 427.15, Narayana Hrudayalaya at Rs 1,895.3 and Latent View Analytics at Rs 201.51. Their return on equity ranges from <strong>10.8% to 17.8%<\/strong>, and their <strong>revenue compound annual growth<\/strong> from FY22 to FY26 ranges from 12.8% to 27.6%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_biotech_chemical_heart_care_and_data_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do biotech chemical, heart care and data stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Biotech chemical, heart care and data stocks have a strong roadmap in India because wider use of specialty chemicals, rising need for affordable specialist care and growing use of data in business decisions keep widening the market for these companies. The main drivers are as follows. Specialty chemicals. Brands need niche formulation inputs. Heart hospitals. Families seek affordable specialist care. Data analytics. Firms use data to decide faster. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Rossari_Biotech_performed_financially\"><\/span><strong>How has Rossari Biotech performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 1,495 crore in FY22 to Rs 2,419 crore in FY26, a compound annual growth rate of 12.8%. Net profit grew from Rs 97.7 crore in FY22 to Rs 149 crore in FY26, which works out to a compound annual growth rate of 11.2%. The company has a return on equity of 10.8%, a debt to equity ratio of 0.28 and a market capitalisation of Rs 2,363 crore. The stock trades at a P\/E of 15.5, below the industry P\/E of 33.9. Looking ahead, the company is broadening its range across home and personal care, animal nutrition and performance chemicals. Cross-selling to existing customers helps add volume.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Narayana_Hrudayalaya_performed_financially\"><\/span><strong>How has Narayana Hrudayalaya performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 3,736 crore in FY22 to Rs 7,996 crore in FY26, a compound annual growth rate of 21.0%. Net profit grew from Rs 342 crore in FY22 to Rs 810 crore in FY26, which works out to a compound annual growth rate of 24.1%. The company has a return on equity of 17.8%, a debt to equity ratio of 1.29 and a market capitalisation of Rs 35,603 crore. The stock trades at a P\/E of 43.6, below the industry P\/E of 59.6. Looking ahead, growth is coming from bed additions across its hospital clusters, a rising share of higher-value specialities and an expanding insurance-led patient base. The group has a track record of running hospitals at high efficiency, which supports margins as scale builds.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Latent_View_Analytics_performed_financially\"><\/span><strong>How has Latent View Analytics performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 429 crore in FY22 to Rs 1,136 crore in FY26, a compound annual growth rate of 27.6%. Net profit grew from Rs 130 crore in FY22 to Rs 202 crore in FY26, which works out to a compound annual growth rate of 11.8%. In the June 2026 quarter, revenue grew 18.8% year on year to Rs 308 crore. The company has a return on equity of 11.3%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 4,968 crore. The stock trades at a P\/E of 25.0, above the industry P\/E of 17.5. Looking ahead, enterprises are investing in analytics and artificial intelligence, which feeds demand for data services. The company is widening its client list and scaling large accounts with a consulting and engineering model.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_biotech_chemical_heart_care_and_data_stocks\"><\/span><strong>What risks should investors check before buying biotech chemical, heart care and data stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying biotech chemical, heart care and data stocks. Raw material and energy costs. Input prices can move margins in chemicals. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Currency moves. Export earnings move with the rupee. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_biotech_chemical_heart_care_and_data_stocks_investment_advice\"><\/span><strong>Is this list of biotech chemical, heart care and data stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 16 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are biotech chemical, heart care and data stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Biotech chemical, heart care and data stocks are listed companies that make specialty chemicals for home care, textiles and animal care, run multi speciality hospitals with a focus on heart care, and provide data analytics services to global clients. Their earnings depend on chemical demand, patient volumes and client technology budgets. This list looks at three of them, Rossari Biotech, Narayana Hrudayalaya and Latent View Analytics, using reported FY22 to FY26 financials and the 16 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which biotech chemical, heart care and data stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Rossari Biotech, Narayana Hrudayalaya and Latent View Analytics. Based on the 16 November 2026 close, Rossari Biotech traded at Rs 427.15, Narayana Hrudayalaya at Rs 1,895.3 and Latent View Analytics at Rs 201.51. Their return on equity ranges from 10.8% to 17.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 12.8% to 27.6%.\"}},{\"@type\":\"Question\",\"name\":\"Why do biotech chemical, heart care and data stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Biotech chemical, heart care and data stocks have a strong roadmap in India because wider use of specialty chemicals, rising need for affordable specialist care and growing use of data in business decisions keep widening the market for these companies. The main drivers are as follows. Specialty chemicals. Brands need niche formulation inputs. Heart hospitals. Families seek affordable specialist care. Data analytics. Firms use data to decide faster. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Rossari Biotech performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 1,495 crore in FY22 to Rs 2,419 crore in FY26, a compound annual growth rate of 12.8%. Net profit grew from Rs 97.7 crore in FY22 to Rs 149 crore in FY26, which works out to a compound annual growth rate of 11.2%. The company has a return on equity of 10.8%, a debt to equity ratio of 0.28 and a market capitalisation of Rs 2,363 crore. The stock trades at a P\/E of 15.5, below the industry P\/E of 33.9. Looking ahead, the company is broadening its range across home and personal care, animal nutrition and performance chemicals. Cross-selling to existing customers helps add volume.\"}},{\"@type\":\"Question\",\"name\":\"How has Narayana Hrudayalaya performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 3,736 crore in FY22 to Rs 7,996 crore in FY26, a compound annual growth rate of 21.0%. Net profit grew from Rs 342 crore in FY22 to Rs 810 crore in FY26, which works out to a compound annual growth rate of 24.1%. The company has a return on equity of 17.8%, a debt to equity ratio of 1.29 and a market capitalisation of Rs 35,603 crore. The stock trades at a P\/E of 43.6, below the industry P\/E of 59.6. Looking ahead, growth is coming from bed additions across its hospital clusters, a rising share of higher-value specialities and an expanding insurance-led patient base. The group has a track record of running hospitals at high efficiency, which supports margins as scale builds.\"}},{\"@type\":\"Question\",\"name\":\"How has Latent View Analytics performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 429 crore in FY22 to Rs 1,136 crore in FY26, a compound annual growth rate of 27.6%. Net profit grew from Rs 130 crore in FY22 to Rs 202 crore in FY26, which works out to a compound annual growth rate of 11.8%. In the June 2026 quarter, revenue grew 18.8% year on year to Rs 308 crore. The company has a return on equity of 11.3%, a debt to equity ratio of 0.02 and a market capitalisation of Rs 4,968 crore. The stock trades at a P\/E of 25.0, above the industry P\/E of 17.5. Looking ahead, enterprises are investing in analytics and artificial intelligence, which feeds demand for data services. The company is widening its client list and scaling large accounts with a consulting and engineering model.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying biotech chemical, heart care and data stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying biotech chemical, heart care and data stocks. Raw material and energy costs. Input prices can move margins in chemicals. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Currency moves. Export earnings move with the rupee. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of biotech chemical, heart care and data stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 16 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Biotech Chemical, Heart Care and Data Stocks with a strong future roadmap: Rossari Biotech, Narayana Hrudayalaya and Latent View Analytics. Compare price, valuation, return on equity and revenue growth as of 16 November 2026.<\/p>\n","protected":false},"author":34,"featured_media":350397,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[3803,24981,24984,24982,24983,24985,9543,7040,10045,6691],"class_list":["post-350398","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-best-stocks","tag-biotech-chemical","tag-cardiac-care-and-data-science-shares","tag-heart-care-and-data-stocks","tag-home-care-ingredient","tag-hospitals-group-and-analytics-services-stocks","tag-latent-view-analytics","tag-narayana-hrudayalaya","tag-rossari-biotech","tag-specialty-chemicals"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["350397"],"rank_math_title":["Biotech Chemical, Heart Hospital and Analytics Stocks"],"rank_math_description":["Compare 3 biotech chemical, heart care and data stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 16 Nov 2026."],"rank_math_focus_keyword":["biotech chemical, heart care and data stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-home-care-and-textile-chemicals-maker-multi-speciality-hospitals-group-and.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/350398","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/34"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=350398"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/350398\/revisions"}],"predecessor-version":[{"id":350399,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/350398\/revisions\/350399"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/350397"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=350398"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=350398"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=350398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}